Rpharmy Marketing
Recent Posts
From Our Customers: The Top 8 Questions To Expect In Joint Commission Inspections
Topics: USP <800>
It seems that you can't turn on the news without hearing about the next wave of COVID-19 that will soon travel across the U.S. Numbers are rising across the nation and there is again a great focus on the capacity of hospital systems to diagnose and treat sick patients, as well as maintain capacity for everyday operations outside of coronavirus care.
While much of the discussion is on the ability to care for the increase in patients, we can't help but focus on the safety of healthcare workers as well.
Topics: Rhazdrugs, USP <800>, Technology
The Human Cost of Not Going Beyond USP 800 Compliance
A shocking 8 million U.S. healthcare workers are potentially exposed to hazardous drugs (HDs) each year according to the CDC. In fact, a report in Pharmacy Times states, “compared with any other occupational setting, the health care setting uses the largest and most diverse array of agents that are hazardous to humans.” Not only are they exposed to a variety of hazardous agents every day, the effects may be compounded over the decades of their career.
Topics: Rhazdrugs, USP <800>, Technology
Rhazdrugs Raises the Bar for USP <800> Compliance
Rpharmy is raising the bar in USP 800 compliance with Rhazdrugs, a searchable hazardous drugs database accessible at the point of care improving visibility, frontline healthcare staff safety, and compliance with regulations including USP 800.
Topics: Rhazdrugs, USP <800>, Technology